The Serum Institute of India has entered into a five-year licensing deal with the University of Oxford, according to a press release on Tuesday (April 16). This partnership aims to produce and distribute a vaccine specifically designed to combat Meningitis-B, a lethal infection affecting the brain and spinal cord. The collaboration signifies an important step toward global health improvement.